Single-Cell Multimodal Functional Glycan Profiling Identifies Novel T Cell Immunomodulatory Glycan Signatures 2309845
The Journal of Immunology · 01.08.2026 · 215 (Supplement_1)
DOI: 10.1093/jimmun/vkag141.1626 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Immunology, online erschienen am 28.07.2026. Verfasst von Ankit Basak und 7 weiteren Autor:innen.
Abstract (Originalsprache)
Introduction
Glycans are key regulators of immune recognition, yet how endogenous human lectins interpret dynamic glycan changes at single-cell resolution remains poorly understood. Existing single-cell omics platforms do not measure functional glycan-lectin interactions, limiting the discovery of glycan-mediated immunoregulatory programs. To address this gap, we developed scGOAT-seq, a multimodal single-cell method that integrates DNA-barcoded recombinant human lectins with transcriptomic profiling to generate physiologically grounded readouts of functional glycan states across diverse immune contexts.
Methods
We curated and validated a panel of recombinant human lectins, including Siglec-7, Siglec-9, Siglec-15, Galectin-8/9, DC-SIGN, and MBL, that collectively span major mammalian glycan classes and applied them using scGOAT-seq on PBMCs under different immune perturbations.
Results
Applied to perturbed peripheral immunity, scGOAT-seq revealed stimulus-specific remodeling of Siglec-ligand landscapes that demarcate discrete immune activation states. In CD4 T cells, Siglec-9L and Siglec-15L distinguished immuno-metabolic, transitional, and effector-like activation programs, whereas Siglec-7L uniquely tracked IL-2-independent activation pathways associated with innate-like stimulation. To probe functional consequences of disrupting these pathways, we blocked Siglec-7/9 receptors during LPS stimulation. Blockade reduced Siglec-ligand display, rewired glycan landscapes across monocytes, NK cells, and T cells, and amplified inflammatory, metabolic, and cytotoxic transcriptional programs. These blockade-induced signatures showed prognostic relevance in TCGA kidney cancer datasets, highlighting their potential translational significance.
Conclusion
Together, scGOAT-seq defines a powerful framework for functional glycan profiling in single cells, revealing previously unrecognized glycan-defined T cell states and offering new avenues for diagnostic stratification and therapeutic glyco-engineering. Funding Source MIT Koch Institute Traditional Bridge Award, MIT School of Science Research Innovation Award, MIT Koch Institute Graduate Fellowship Topic Categories Technological Innovations in Immunology (TECH)
Zitieren
APA
Basak, A., Cordero, C. O., Yiu, S. P. T., Allison, S., Sweeting, S., Jiang, S., Shalek, A., & Kiessling, L. (2026). Single-Cell Multimodal Functional Glycan Profiling Identifies Novel T Cell Immunomodulatory Glycan Signatures 2309845. The Journal of Immunology, 215(Supplement_1). https://doi.org/10.1093/jimmun/vkag141.1626
Vancouver
Basak A, Cordero CO, Yiu SPT, Allison S, Sweeting S, Jiang S, et al. Single-Cell Multimodal Functional Glycan Profiling Identifies Novel T Cell Immunomodulatory Glycan Signatures 2309845. The Journal of Immunology. 2026;215(Supplement_1). doi:10.1093/jimmun/vkag141.1626
BibTeX
@article{Basak2026,
author = {Basak, Ankit and Cordero, Carolina Ortiz and Yiu, Stephanie Pei Tung and Allison, Sidney and Sweeting, Sarah and Jiang, Sizun and Shalek, Alex and Kiessling, Laura},
title = {Single-Cell Multimodal Functional Glycan Profiling Identifies Novel T Cell Immunomodulatory Glycan Signatures 2309845},
journal = {The Journal of Immunology},
year = {2026},
volume = {215},
number = {Supplement_1},
doi = {10.1093/jimmun/vkag141.1626}
}
EUVIMED